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1684-1182/Copyright ª 2015, TaiwanResistance of pathogenic microorganisms to antibiotics is a serious global health concern. In this
review, research investigating the antimicrobial properties of honeys from around the world
against skin relevantmicrobes is evaluated. A plethora of in vitro studies have revealed that hon-
eys from all over the world have potent microbicidal activity against dermatologically important
microbes. Moreover, in vitro studies have shown that honey can reduce microbial pathogenicity
as well as reverse antimicrobial resistance. Studies investigating the antimicrobial properties of
honey in vivo have been more controversial. It is evident that innovative research is required to
exploit the antimicrobial properties of honey for clinical use and to determine the efficacy of
honey in the treatment of a range of skin disorders with a microbiological etiology.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
In traditional medicine, honey has been recognized around
the world for its skin-healing properties. The ancient
Greeks and Egyptians, for example, used topical applica-
tion of honey to treat skin wounds and burns, and Persianutrition, and Biological Sci-
usselburgh, Queen Margaret
d, United Kingdom.
L. Fyfe).
.01.009
Society of Microbiology. Publishedtraditional medicine documented honey to be effective in
the treatment of wounds, eczema, and inflammation.1,2
Microorganisms have been associated with the patho-
physiology of a range of dermatological disorders. Wound
infections, for example, are commonly caused by the mi-
croorganisms Staphylococcus aureus, Pseudomonas aerugi-
nosa, and Escherichia coli, and infection with S. aureus is
common in atopic dermatitis.3,4 Another example is
Malassezia yeasts, which have been associated with the
skin conditions pityriasis versicolor, seborrheic dermatitis,
atopic dermatitis, and psoriasis.5 Conventional treatments
for some of these conditions are unsatisfactory, e.g.,by Elsevier Taiwan LLC. All rights reserved.
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apy has been associated with the development of skin
cancer.6
Scientists first reported the ability of honey to kill
disease-causing microbes in the late 1800s, but with the
advent of antibiotics in the early 1900s, scientific interest
in honey waned.7 Today, with the emergence of antibiotic-
resistant microbial strains, such as methicillin-resistant S.
aureus (MRSA)da cause of difficult-to-treat wound in-
fections and a global health concern, honey has again
caught the attention of medical researchers.7,8
In clinical practice today, Manuka honey produced by
honey bees (Apis mellifera) collecting nectar from the
Manuka tree (Leptospermum scoparium) is used topically in
the management of wound infections.9 Products include
gamma-irradiated honey in gels, ointments, and impreg-
nated dressings. Revamil honey is another medical-grade
honey commonly used in clinical practice for wound
care.10 It is produced in greenhouses by manufacturers in
The Netherlands, but further details about the origin of this
honey have not been disclosed.
In this review, research findings on the antimicrobial
activities of honeys from around the world, against skin
relevant microbes, are evaluated. Furthermore, mecha-
nisms of the antimicrobial properties of honey are
explored. The principal aim was to understand more about
the therapeutic potential of honey as a treatment option
for skin diseases with a microbiological etiology.Antimicrobial properties of Manuka honey
against skin relevant microbes: in vitro studies
The most widely researched honey, to date, is Manuka honey
fromNewZealand. Studies have shown thatManukahoney has
antimicrobial activity in vitro against the most common
wound-infecting microorganisms, including MRSA, S. aureus,
P. aeruginosa, and E. coli.11,12 Manuka honey can also inhibit
the growth of Streptococcus pyogenes, a cause of cellulitis,
impetigo, and necrotizing fasciitis, and the dermatophyte
Trichophyton mentagrophyte, a cause of ringworm.11,13
Indeed, Manuka honey has been shown to inhibit the growth
of a range of dermatophytes, including Epidermophyton
floccosum, Microsporum canis, Microsporum gypseum, Tri-
chophyton rubrum, and Trichophyton tonsurans, indicating
that honey may be a therapeutic in the treatment of derma-
tophytosis (tinea infections).13 Studies have reported that
Candida albicans is more resistant to Manuka honey than
many other microbial species.14,15 Manuka honey has also
been shown to have antiviral activity in vitro against varicella
zoster virus, suggesting that honey may be a therapeutic for
viral skin rashes.16 The antiviral properties of honey against
other skin relevant viruses such as human papilloma virusmay
be worth investigating.
As the antimicrobial activity of honey varies not only
between different types of honey but also between batches
of the same type of honey, Manuka honey is often ascribed
a unique Manuka factor (UMF). The UMF is a measure of the
strength of the antibacterial activity of the honey against S.
aureus and is calculated based on the concentration of a
phenol solution that gives a similar zone of growth inhibi-
tion, in a radial diffusion assay, to the honey being tested. Acriticism of the UMF classification is that it is a measure of
activity against S. aureus only and not against other rele-
vant microbes.
Antimicrobial activity of honeys from around
the world against skin relevant microbes:
in vitro studies
A plethora of scientific papers have reported in vitro anti-
microbial activity of honeys from all over the world; some
examples are discussed in this section.
Honey produced in South Gondar, Ethiopia, by the bee
Apis mellipodae, a stingless bee, is used in traditional
medicine in Ethiopia to treat a variety of diseases including
skin infections.17 Using the method of agar well diffusion,
Andualem17 demonstrated that this honey inhibited the
growth of the wound-infecting microbes E. coli and S.
aureus with minimal inhibitory concentrations (MICs) of
12.5% and 6.25%, respectively.
In a study by Pimentel et al,18 honey samples collected
from the stingless bee Melipona compressipes manaosensis
in Manaus, Amazonas, Brazil, were active against E. coli, S.
aureus, Proteus vulgaris, and Klebsiella species. Using agar
well diffusion assays, it was demonstrated that honey
collected during the rainy season inhibited the growth of E.
coli only in the undiluted form, while honey collected during
the dry season inhibited the growth of E. coli, S. aureus, and
a range of other microbes at much more diluted concentra-
tions. These results clearly show the influence of seasonality
on the antibacterial activity of honey. Plant-derived factors
or entomological factors such as the health of the bee col-
onies can be affected by seasons, with consequences for the
antimicrobial activity of the honey produced. Researchers
also compared the ability of honey to inhibit microbial
growth evaluated by agar well diffusion with that assessed
by a broth dilution assay, and found that the broth dilution
assay was amore sensitive method, most likely due to better
movement of the antimicrobial components of honey in
liquid broth than in agar. Rutin, a flavonoid previously shown
to have antibacterial activity, was identified in honey by
high-performance liquid chromatography.
Kuncic et al19 reported that Slovenian honeys from
diverse floral origins had antibacterial activity against E.
coli, P. aeruginosa, and S. aureus. Slovenian chestnut and
pasture honeys were found to be most active; for example,
the MIC of the chestnut honey against S. aureus was found
to be 2.5%. C. albicans was not inhibited by any of the
Slovenian honeys tested, and Candida parapsilosis and
Candida tropicalis were inhibited only by honey of con-
centrations higher than 50%.
In other studies, the growth of C. albicans was inhibited
by Jujube honey, a honey obtained from bee keepers in Al-
baha, Saudi Arabia, prepared by bees feeding on the plant
Ziziphus jujuba, and by a mixture of honey, olive oil, and
beeswax containing multifloral honey from the United Arab
Emirates.20,21 Such findings indicate the potential of some
honeys for use in the treatment of skin disorders caused by
C. albicans such as cutaneous candidiasis.
Tualang honey, obtained from bees (Apis dorsata)
feeding on Tualang trees (Koompassia excelsa) in the jun-
gles of Malaysia, was found to inhibit the growth of MRSA, S.
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in a broth dilution assay, with MICs comparable with those
of Manuka honey.11
In 2013, researchers at Queen Margaret University,
Edinburgh, Scotland, reported the antimicrobial activity of
a Scottish honey, called Portobello honey.22 Portobello
honey was produced by honey bees in an apple orchard in
Portobello, Edinburgh, Scotland. Five concentrations of the
Portobello honey and medical-grade Manuka Honey (0%, 1%,
10%, 50%, and 70%) were tested against S. aureus, P. aer-
uginosa, and E. Coli using agar disc diffusion and a broth
dilution assay. The agar disc diffusion method did not
demonstrate any antimicrobial activity of the honeys
tested; however, it was reported that the honey remained
on the surface of the disc and did not diffuse into the agar.
The broth dilution assay, by contrast, demonstrated anti-
microbial activity of Portobello and Manuka honeys at
concentrations of 50% and 70%, which were found to inhibit
the majority of all the bacterial species tested. The MIC of
Portobello honey was not calculated, but the authors
concluded that honey is a superior antibacterial agent.
In a study by Carnwath et al,23 the antimicrobial activities
of a selection of 10 honeys against 10 microorganisms were
tested at the Department of Veterinary Medicine, University
of Glasgow, Scotland. The honeys tested included medical-
grade and shop-bought Manuka honeys, Scottish heather
honey (from a local bee keeper), blossom honey, Vipers
bugloss honey, Inverness floral honey, and Glasgow floral
honey. Themicroorganisms tested included MRSA, S. aureus,
E. coli, P. aeruginosa, and Acinetobacter baumannii. Serial
dilutions of the honeys were prepared in distilled water and
mixed with equal volumes of nutrient agar, to produce final
honey concentrations ranging from 2% to 16%. Plates were
inoculated with the appropriate microorganism and incu-
bated aerobically overnight. All the honeys tested demon-
strated antimicrobial activity, but the Scottish heather
honey was found to be most active, which inhibited the
growth of all the microorganisms tested, with MICs ranging
from <2% to 6%. The Scottish heather honey was even more
active than all the Manuka honeys used in the study.
Remarkably, in vitro research has also shown that honey
can actually reverse antibiotic resistance, suggesting that
honey used in combination with antibiotics may have
additional therapeutic effects.24 A suggested mechanism is
via honey-induced downregulation of mecR1 gene product,
a transducer associated with antibiotic resistance in MRSA.
Indeed, Muller et al25 reported that Manuka honey workedTable 1 Activity of some honeys from around the world agains
Type of honey MRSA Staphylococcus
aureus
Pseudomonas
aeruginosa
Manuka honeya þ(12) þ(11) þ(11,12)
Scottish heather honeyb þ(23) þ(23) þ(23)
Portobello honeyb Ϯ þ(22) þ(22)
Tualang honeyc þ(11) þ(11,27) þ(11,27)
a New Zealand.
b Scotland.
c Malaysia.
Numbers in brackets are references.
HPV Z human papilloma virus; MRSA Z methicillin-resistant S. aureusynergistically with the antibiotic rifampicin to inhibit the
growth of MRSA and clinical isolates of S. aureus.
The evidence is clear that, in a laboratory setting, honeys
from all over the world have potent antimicrobial activity
against skin relevant microbes (Table 1). Indeed, the anti-
microbial activity of honey from Iran has been shown to be
comparable with that of the sulfonamide family of antibi-
otics.26 The microorganism S. aureus is clearly inhibited by
honeys of different floral origins. In addition to wound in-
fections, S. aureus is an important cause of furuncles, styes,
and impetigo. Honey has broad-spectrum antimicrobial
properties; it may also have therapeutic value in the treat-
ment of other skin disorders, in which microbes have been
associated with the etiology of the disease, as well as those
disorders that are commonly treated with topical antibi-
otics, e.g., acne. Analysis of the antimicrobial activity of
different types of honeys against other dermatologically
relevant microbes should be encouraged.Antimicrobial properties of honey: in vivo
human studies
The majority of studies to date have demonstrated the
antimicrobial activity of honey against a range of microbial
strains including clinical isolates, using in vitro antimicrobial
assays. Fewer studies have demonstrated the antimicrobial
activity of honey in vivo; studies carried out so far have
mainly investigated the antimicrobial activity of honey in
relation to wound infections. In the 1st decade of the 21st
century, several case studies involving wound patients pro-
duced optimistic findings. A brief report by Cooper et al28
described how treatment of a S. aureus-infected, recalci-
trant surgical wound in a 38-year-old female with Manuka
honey-impregnated dressings and oral coamoxiclav resulted
in significant healing of the wound and bacterial clearance 7
days after commencing the treatment. The wound was 3
years old, and had failed to respond to other conventional
wound treatments and antibiotics during the 3-year period
prior to commencing the honey/antibiotic combination
therapy. Natarajan et al29 treated an MRSA-infected leg
ulcer of an immunosuppressed patient with topical appli-
cation of Manuka honey; consequently, MRSAwas eradicated
and the wound successfully healed. Chambers30 reported
bacterial clearance in three cases of MRSA-infected leg ul-
cers following treatment with topical Manuka honey, while
Visavadia et al31 reported that Manuka honey, based ont common skin relevant microbes
Escherichia
coli
Candida
albicans
Dermatophytes Malassezia
species
HPV
þ(11,12) (14,15) þ(13) Ϯ Ϯ
þ(23) Ϯ Ϯ Ϯ Ϯ
þ(22) Ϯ Ϯ Ϯ Ϯ
þ(11,27) Ϯ Ϯ Ϯ Ϯ
s; þ Z active;  not active or low activity; Ϯ Z unknown.
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ments for infected wounds at the Maxillofacial Unit at the
Royal Surrey County Hospital, Guildford, Surrey.
Larger clinical studies have produced more controversial
findings. Gethin and Cowman32 recruited 108 patients with
venous leg ulcers and treated them with either Manuka
honey or hydrogel. In their study, Manuka honey success-
fully eliminated MRSA from 70% of MRSA-infected wounds;
in comparison, hydrogel eradicated MRSA from only 16% of
infected wounds. For P. aeruginosa-infected wounds,
Manuka honey cleared infection in just 33% of wounds,
whereas hydrogel cleared infection in 50% of wounds. Jull
et al,33 in a randomized clinical trial of 368 participants,
reported no significant difference in occurrence of infec-
tion in venous leg ulcers treated with either Manuka honey-
impregnated dressings or usual care. Another clinical study
showed no significant difference, in terms of development
of peritoneal dialysis-related infections when patients un-
dergoing peritoneal dialysis were treated with either Med-
ihoney antibacterial wound gel (containing honey from
Leptospermum species) or the topical antibiotic mupirocin
applied to catheter exit sites.34Antimicrobial properties of honey: in vivo
animal studies
Antimicrobial effects of honey have been observed in an-
imal studies in vivo. Al-Waili35 reported that application of
a natural honey from the United Arab Emirates to S.
aureus or Klebsiella species-inoculated surgical wounds
induced in mice reduced the time for bacterial elimination
to occur. Khoo et al36 reported that Tualang honey was
superior to hydrofiber and hydrofiber silver dressings in
reducing the growth of bacteria in P. aeruginosa-inocu-
lated burn wounds induced in Sprague Dawley rats.
Conversely, hydrofiber and hydrofiber silver dressings were
superior to Tualang honey in reducing bacterial growth in
A. baumannii-inoculated wounds, while there was no sig-
nificant difference between the three treatments in
inhibiting the growth of bacteria in Klebsiella pneumo-
niae-inoculated wounds. Gunaldi et al37 investigated the
antimicrobial activity of Manuka honey in clearing MRSA
infection in MRSA-inoculated spinal implants inserted in
rats. The results showed that while Manuka honey signifi-
cantly reduced MRSA growth on the implants, it did not
eradicate the MRSA entirely. In the vertebral column of
the rats, MRSA growth was also reduced more in the
Manuka honey-treated group compared to the control
group, but this was not statistically significant.
It could be said that the research findings for the anti-
microbial activity of honey in vivo have not been as
“outstanding” as those observed in vitro, and the reasons
for this require investigation. Human and animal cells are
known to contain the enzyme catalase, an enzyme that
breaks down hydrogen peroxide (an important antimicro-
bial component of some honeys) into hydrogen and oxygen.
If the antimicrobial properties of honey are due to
hydrogen peroxide, the antimicrobial activity may be
reduced when honey comes into contact with live cells.38
Innovative research that can overcome obstacles associ-
ated with in vivo use of honey is urgently required.It is also important to consider that some honeys have
been shown to be contaminated with bacteria and fungi,
and therefore non-gamma-irradiated honeys may not be
suitable for application on damaged skin.23 The production
of medical-grade honeys, suitable for use in clinical prac-
tice, from local honeys would be economically advanta-
geous and beneficial to local communities.Effects of honey on microbial pathogenicity of
skin relevant microbes: in vitro studies
Incredibly, recent research has shown that the antimicro-
bial properties of honey in vitro are more than bactericidal
because honey has also been shown to reduce bacterial
pathogenicity. The ability of pathogenic microbes to cause
diseases is partly due to the production of pathogenicity
factors. S. aureus, for example, produces a range of
disease-causing proteins, including catalase, hemolysins (a,
b, g, and d), epidermolytic toxins, and enterotoxins. Alpha-
toxin (a-hemolysin) causes tissue damage during wound
infections by creating pores in host cell membranes,
allowing the discharge of low-molecular-weight com-
pounds, and by inducing cytokine production and apoptosis.
Recently, Jenkins et al39 reported that Manuka honey
reduced the expression of a-toxin in MRSA. Expression of
other virulence genes, quorum sensing genes, and genes
associated with cell division was also reduced. Lee et al40
reported that three types of honeys (Korean acacia,
Korean polyfloral, and American clover honeys) at a con-
centration as low as 0.5% significantly inhibited pathogenic
E. coli O157:HA biofilm formation in vitro. Furthermore,
low concentrations of the Korean acacia honey reduced the
expression of curli genes (csgBAC ), quorum sensing genes
(AI-2 importer, indole biosynthesis), and virulence genes
(LEE genes) in the bacterial strain. Kronda et al41 reported
that sublethal concentrations of Manuka honey reduced
siderophore production, a virulence factor that scavenges
iron for bacterial growth, in clinical and nonclinical strains
of P. aeruginosa. Manuka honey has also been shown to
alter the structure of P. aeruginosa; scanning and trans-
mission electron microscopy revealed changes in cell shape
and cell lysis following incubation with honey.42 A honey
flavonoid extract was also found to alter membrane integ-
rity and branching processes associated with virulence in C.
albicans.43
In addition to the more commonly investigated wound
pathogens, subinhibitory concentrations of Manuka honey
and Slovakian honeys (Hawthorn, honeydew, and acacia)
significantly inhibited Proteus mirabilis and Enterobacter
cloacae biofilm formation in vitro.44
In vivo studies investigating the efficacy of sublethal
concentrations of honey against biofilms would advance our
knowledge of the ability of honey to modulate bacterial
pathogenicity.Antimicrobial mode of action of honey
The antimicrobial properties of honey have been attributed
to its multiple components, including high sugar concen-
tration, low pH, hydrogen peroxide (H2O2), methylglyoxal
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compounds such as polyphenols that have not been fully
elucidated.
The high sugar concentration and low moisture content
of honey cause osmotic stress to microbial cells, and low pH
is unfavorable for the growth of many microorganisms.
However, if a sugar solution with identical sugar compo-
nents and pH to that of honey is prepared, the antimicro-
bial activity of the sugar solution is often considerably
lower than that of honey, suggesting that other factors in
the honey are responsible for its antimicrobial activity.23
Honey bees add an enzyme, called glucose oxidase, to
the collected nectar during the honey-making process,
which converts the glucose in the honey into hydrogen
peroxide (H2O2) and gluconic acid. H2O2 is toxic to many
microbes. During the ripening of honey, glucose oxidase is
inactivated but regains its activity if the honey is diluted. In
a study by Kwakman et al,10 it was found that Revamil
honey produced 3.47  0.25 mM H2O2 in 40% (v/v) honey
after 24 hours, but no H2O2 was detectable in the Manuka
honey they tested, suggesting that nonperoxide factors are
responsible for the antimicrobial activity of Manuka honey.
Manuka honey has been shown to contain high levels of
MGO, 44-fold higher than Revamil honey. MGO in Manuka
honey is produced by the nonenzymatic conversion of
dihydroxyacetone present at high concentrations in the
nectar of L. scoparium flowers. The change occurs slowly
during honey storage. Kwakman et al10 reported that
neutralization of MGO in Manuka honey abolished the
antimicrobial activity of the honey against S. aureus, but
did not abolish the antimicrobial activity against E. coli and
P. aeruginosa. The authors concluded that MGO is not fully
responsible for Manuka honey’s nonperoxide antimicrobial
activity and that other components, possibly polyphenols,
may be responsible.
Polyphenols derived from plant nectar are natural
organic chemicals characterized by the presence of multi-
ple phenol structural units. Many are antioxidants, e.g.,
flavonoids. The antibacterial properties of flavonoids have
been attributed to the inhibition of bacterial energy
metabolism, bacterial DNA gyrase, and cytoplasmic mem-
brane function.45 Researchers in New Zealand identified
the polyphenol methyl syringate as the major component of
the phenolic fraction of Manuka honey.46 A novel glycoside
of methyl syringate, named leptosin, was recently identi-
fied in Manuka honey, and its levels were found to correlate
positively with the UMF.47 Identification of phenolic com-
pounds in honey may be important for the production of
new antimicrobials, and therefore the analysis of the
phenolic profile of active honeys should be encouraged.
Combinations of polyphenols may be more effective, as
they may act synergistically to inhibit microbial growth, or
structural alteration of individual polyphenols can be
employed to enhance antimicrobial activity.
Bee defensin-1 is an antimicrobial peptide that is part of
the honey bee innate immune system. It is secreted by the
hypopharyngeal gland of honey bees and can enter honey
via bee saliva during the regurgitation process of honey
making. Bee defensin-1 has a strong activity against Gram-
positive bacteria including S. aureus. Kwakman et al48
identified bee defensin-1 in Revamil honey but not in
Manuka honey.Raw honey may also contain propolis, a substance
composed of plant resins and used by bees to seal the hive.
Scientific research has shown that propolis has antimicro-
bial properties.49
The research of Kwakman et al48 demonstrates the di-
versity and complexity of the antimicrobial components of
different types of honeys. Analysis of the antimicrobial
components of other active honeys will be important for a
fuller understanding of their applicability in medicine.
It can be concluded from in vitro studies that honey has
powerful antimicrobial activity against dermatologically
relevant microbes. These findings are particularly prom-
ising in current times when the problem of antimicrobial
drug resistance is considered a global crisis and the World
Health Organization (2014)50 has acknowledged the possi-
bility of a postantibiotic era in which common infections
can kill. Even more exciting are the in vitro findings that
honey can reverse antimicrobial resistance and reduce
microbial pathogenicity. Despite these optimistic findings
in vitro, the use of honey in clinical practice today as an
antimicrobial agent does not appear to have yet reached its
full potential. Innovative research that can maximally
exploit the antimicrobial properties of this natural sub-
stance and overcome obstacles associated with in vivo use
may, in the future, lead to the production of an antimi-
crobial agent that is highly valued in clinical practice.
Interestingly, no honey-resistant microbial strains have
emerged to date, and this may be unlikely because of the
multifactorial nature of the antimicrobial properties of
honey. As honeys from diverse floral origins have been
shown to have antimicrobial activity against a range of skin
relevant microbes, research should continue to investigate
the efficacy of honey in the treatment of other types of skin
disorders where microbes have been implicated in the
pathophysiology of the disease. There are countless vari-
eties of honeys being produced worldwide, and some may
have superior antimicrobial activities that are yet to be
discovered.References
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